Cost-utility analysis of the use of a wearable cardioverter defibrillator (LifeVest®) versus standard of care in the prevention of sudden cardiac death in patients after myocardial infarction

Key Points

Wearable cardioverter defibrillator reduces the risk of sudden cardiac death significantly in at-risk patients after myocardial infarction, enhancing safety.
The cost-utility analysis highlights that the LifeVest® device presents a favorable economic profile compared to standard care, saving costs associated with treatments.
Utilizing a cost-utility analysis, findings reveal a beneficial trade-off between the cost and health outcomes within a population recovering from myocardial infarction.
This study underscores the economic viability of adopting wearable cardioverter defibrillators for sudden death prevention, warranting broader application.

Answers are grounded in this paper and cite their sources.

Cost-utility analysis compares wearable cardioverter defibrillator and standard care in myocardial infarction patients, suggesting improved outcomes.

Not available Keywords: cost-effectiveness analysiscost-utility analysismyocardial infarctionsudden cardiac deathwearable cardioverter defibrillator

No takes yet. Share an insight, caveat, or question.

Mitkowski et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share